Biologic properties and clinical uses of rifaximin

Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations

(2014) E.A. Debbia et al.   JOURNAL OF CHEMOTHERAPY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bile Acids Improve the Antimicrobial Effect of Rifaximin

(2010) C. Darkoh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy

(2010) Lucio Lombardo et al.   Clinical Gastroenterology and Hepatology

Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei

(2010) Zhi-Dong Jiang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas

(2010) Z-D Jiang et al.   JOURNAL OF CLINICAL PATHOLOGY

Prevention of Travelers' Diarrhea With Rifaximin in US Travelers to Mexico

(2010) Francisco Martinez‐Sandoval et al.   JOURNAL OF TRAVEL MEDICINE

Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series

(2010) Guy Neff et al.   LIVER TRANSPLANTATION

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment

(2009) Stuart Johnson et al.   ANAEROBE

Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles

(2009) E. L. Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use and Safety of Rifaximin in Children With Inflammatory Bowel Disease

(2009) Pramodha Muniyappa et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Expert Review of the Evidence Base for Self‐Therapy of Travelers’ Diarrhea

(2009) Herbert L. DuPont et al.   JOURNAL OF TRAVEL MEDICINE

Expert Review of the Evidence Base for Prevention of Travelers’ Diarrhea

(2009) Herbert L. DuPont et al.   JOURNAL OF TRAVEL MEDICINE

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

(2009) Sergio Peralta et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Small Intestinal Bacterial Overgrowth Recurrence After Antibiotic Therapy

(2008) Ernesto C. Lauritano et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Rifamycin Antibiotics for Treatment of Clostridium difficile–Associated Diarrhea

(2008) Kevin W Garey et al.   ANNALS OF PHARMACOTHERAPY

Rifaximin for maintenance therapy in antibiotic-dependent pouchitis

(2008) Bo Shen et al.   BMC GASTROENTEROLOGY

Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability

(2008) J. Ruiz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study

(2008) Kevin W. Garey et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY